NF-κB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium

Alcohol

Volumn 41, Issue 6, 2007, Pages 447-460

  Banan, A ^a   Keshavarzian, A ^a   Zhang, L ^a   Shaikh, M ^a   Forsyth, C B ^a   Tang, Y ^a   Fields, J Z ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Actin; ALD; Caco 2 cells; Cytoskeleton; Gut barrier integrity; Transfection and molecular biology

Indexed keywords

ALCOHOL; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; F ACTIN; G ACTIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTACYSTIN; TRANSCRIPTION FACTOR RELA; ACTIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; INTESTINE EPITHELIUM; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; WESTERN BLOTTING; ALCOHOL LIVER DISEASE; CELL STRAIN CACO 2; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; INTESTINE MUCOSA; METABOLISM;

ACTINS; CACO-2 CELLS; CYTOSKELETON; ETHANOL; HUMANS; I-KAPPA B PROTEINS; INTESTINAL MUCOSA; LIVER DISEASES, ALCOHOLIC; NF-KAPPA B;

EID: 35048812999     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2007.07.003     Document Type: Article

References (63)

1. Baeuerle P.A., and Henkle T. Function and activation of NF-kB in immune system. Annu. Rev. Immunol. 12 (1994) 141-179
2. Banan A., Choudhary S., Zhang Y., Fields J.Z., and Keshavarzian A. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J. Pharmacol. Exp. Ther. 291 3 (1999) 1075-1085
3. Banan A., Choudhary S., Zhang Y., Fields J.Z., and Keshavarzian A. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radical Biol. Med. 28 5 (2000) 727-738
4. 2)-induced disruption of intestinal epithelium. J. Pharmacol.Exp. Ther. 306 (2003) 13-28
5. Banan A., Fields J.Z., Talmage D.A., Zhang L., Farhadi A., and Keshavarzian A. The β1 isoform of protein kinase C mediates the protective effects of EGF on the dynamic assembly of the cytoskeleton through normalization of calcium homeostasis in human colonic cells. J. Pharmacol. Exp. Ther. 310 (2002) 852-866
6. Banan A., Fields J.Z., Talmage D.A., Zhang L., Farhadi A., and Keshavarzian A. PKC-ζ isoform prevents oxidant-induced iNOS upregulation and protects the microtubule cytoskeleton and intestinal barrier integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G909-G922
7. Banan A., Fields J.Z., Talmage D.A., Zhang L., and Keshavarzian A. The atypical PKC-ζ isoform is required in protection of microtubules and intestinal barrier integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G794-G808
8. Banan A., Fields J.Z., Talmage D.A., Zhang Y., and Keshavarzian A. The β1 isoform of protein kinase C mediates epidermal growth factor protection of the microtubules and barrier integrity of intestinal monolayers against oxidant damage. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G833-G847
9. 2-induced oxidation and disassembly of F-actin cytoskeleton and loss of epithelial barrier. Am. J. Physiol. Cell Physiol. 285 4 (2003) C977-C993
10. Banan A., Fields J.Z., Zhang L.J., Shaikh M., Farhadi A., and Keshavarzian A. The atypical zeta (ζ) isoform of protein kinase C prevents oxidant-induced NF-κB activation in the intestinal epithelium. J. Pharmacol. Exp. Ther. 307 (2003) 53-66
11. Banan A., Fields J.Z., Zhang Y., and Keshavarzian A. NO and its metabolites mediate ethanol-induced microtubule disruption in intestinal monolayers. J. Pharmacol. Exp. Ther. 294 3 (2000) 997-1008
12. Banan A., Fields J.Z., Zhang Y., and Keshavarzian A. Key role of general protein kinase C activation in EGF-induced protection of the microtubule cytoskeleton and intestinal epithelial barrier against oxidant injury. Am. J. Physiol. Gastrointest. Liver Physiol 280 (2001) G828-G843
13. Banan A., Fields J.Z., Zhang Y., and Keshavarzian A. Targeted molecular inhibition of phospholipase C-γ prevents EGF-mediated protection of the microtubule cytoskeleton and intestinal epithelial barrier function against oxidant injury. Am. J. Physiol. Gastrointest. Liver Physiol 281 (2001) G412-G423
14. 2)-induced disruption of F-Actin and the permeability barrier of intestinal monolayers. Am. J. Physiol. 280 (2001) G1234-G1246
15. Banan A., McCormack S.A., and Johnson L.R. Polyamines are required for cytoskeletal formation during mucosal ulcer healing. Am. J. Physiol. Gastrointest. Liver Physiol. 274 37 (1998) G879-G885
16. Banan A., Shaikh M., Fields J.Z., Farhadi A., Mutlu E., and Keshavarzian A. Upregulation of NF-κB and I-κBα degradation and consequent cytoskeletal dysfunction in colonic mucosa of patients with inflammatory bowel disease (IBD). Gastroenterology (abst) 124 No. 4 Suppl 1 (2003) S1338
17. Banan A., Smith G.S., Rickenberg C., Kokoska E.R., and Miller T.A. Protection against ethanol injury by prostaglandins in a human intestinal cell line: role of cytoskeleton. Am. J. Physiol. Gastrointest Liver Physiol. 274 37 (1998) G111-G121
18. Banan A., Wang J.Y., McCormack S.A., and Johnson L.R. Relationship between polyamines, actin cytoskeletal distribution, and gastric mucosal ulcer healing in rats. Am. J. Physiol 34 5 (1996) G893-G903
19. Banan A., Zhang L.J., Shaikh M., Fields J.Z., Farhadi A., and Keshavarzian A. Protein kinase C-βeta1 isoform is required for EGF-induced NF-κB inactivation and I-κBα stabilization in enterocyte monolayers. Am. J. Physiol. Cell Physiol 286 3 (2004) C723-C738
20. Banan A., Zhang Y., Hutte R., and Keshavarzian A. Increased oxidation and nitration injury in intestinal mucosa of patients with inflammatory bowel disease. Gastroenterology 118 4, Pt 1 (2000) 4266
21. 2)-induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor-α in a human intestinal cell line. Gut 46 (2000) 830-837
22. Barnes P.J., and Karin M. Nuclear factor-kB, a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
23. Bjorkman D.J., and Jessop L.D. Effects of acute and chronic ethanol exposure on intestinal microvillous membrane lipid composition and fluidity. Alcohol. Clin. Exp. Res. 18 3 (1994) 560-565
24. Bode C., Kugler V., and Bode J.C. Endotoxemia in patients with alcoholic and nonalcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol. 4 (1987) 8-14
25. Bonizzi G., Piette J., Merville M.P., and Bours V. Cell type-specific role for reactive oxygen species in nuclear factor-kappa B activation by interleukin-1. Biochem. Pharmacol. 59 1 (2000) 7-11
26. Bradford M.A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye binding. Anal. Biochem. 72 (1976) 224-254
27. Chen F., Sun S.C., Kuh D.C., Gaydos L.J., and Demers L.M. Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages. Biochem. Biophys. Res. Comm. 214 3 (1995) 985-992
28. Dinda P.K., Kossev P., Beck I.T., and Buell M.G. Role of xanthine oxidase-derived oxidants and leukocytes in ethanol-induced jejunal mucosal injury. Dig. Dis. Sci. 41 12 (1996) 2461-2470
29. Gobejishvili L., Barve S., Joshi-Barve S., Uriarte S., Song Z., and McClain C. Chronic ethanol-mediated decrease in cAMP primes macrophages to enhance LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease. Am. J. Physiol. Gastrointest Liver Physiol. 291 4 (2006) G681-G688
30. Harter J.L. Critical values for Dunnett's new multiple range test. Biometrics 16 (1960) 671-685
31. Hermiston M.L., and Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270 (1995) 1203-1207
32. Hill D.B., Barve S., Joshi-Barve S., and McClain C. Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis. J. Lab. Clin. Med. 135 (2000) 387-395
33. Hollander D. The intestinal permeability barrier: a hypothesis as to its regulation and involvement in Crohn's disease. Scand. J. Gastroenterol. 27 (1992) 721-726
34. Hollander D. Crohn's disease-a permeability disorder of the tight junction?. Gut 26 (1998) 1621-1624
35. Hurani M.A., Noach A.B., Blom-Roosemalen C.M., DeBoer A.G., Nagelkerke J.F., and Breimer D.D. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrosulfate: assessment of effect-reversibility and imaging of transepithelial transport routes by laser confocal microscopy. J. Pharmacol. Exp. Ther. 267 (1993) 942-950
36. Jobin C., Bradham C.A., Russo M.P., Juma B., Narula A.S., Brenner D.A., and Sartor R.B. Curcumin blocks cytokine-mediated NF-kB activation and proinflammatory gene expression by inhibiting inhibitory factor I-kB kinase activity. J. Immunol. 163 (1999) 3474-3483
37. Kennedy M., Denenberg A.G., Szabo C., and Salzman A.L. Poly (ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 114 (1998) 510-518
38. Keshavarzian A., Banan A., Farhadi A., Kommandori S., Zhang Y., and Fields J.Z. Increases in colonic free radicals and in cytoskeletal protein oxidation and nitration in the colonic mucosa of patients with inflammatory bowel disease. Gut 52 5 (2003) 720-728
39. Keshavarzian A., Choudhary S., Holmes E.W., Banan A., and Fields J.Z. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J. Pharmacol. Exp. Ther. 299 2 (2001) 442-448
40. Keshavarzian A., Fields J., Vaeth J., and Holmes E. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am. J. Gastroenterol. 89 12 (1994) 2205-2211
41. Keshavarzian A., Holmes E.W., Patel M., Iber F., and Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol induced liver damage. Am. J. Gastroenterol. 94 (1999) 200-207
42. Keshavarzian A., Sedghi S., Kanofsky J., List T., Robinson C., Ibrahim C., and Winship D. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 103 (1992) 177-185
43. Kretz-Remy C., Mehlen P., Mirault M.E., and Arrigo A.P. Inhibition of I-kB-phosphorylation and degradation and subsequent NF-kB activation by glutathione peroxidase over-expression. J. Cell Biol. 133 (1996) 1083-1093
44. Mandrekar P., Bellerose G., and Szabo G. Inhibition of NF-kappa B binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human. Alcohol. Clin. Exp. Res. 26 12 (2002) 1872-1879
45. Mandrekar P., Dolganiuc A., Bellerose G., Kodys K., Romics L., Nizamani R., and Szabo G. Acute alcohol inhibits the induction of nuclear regulatory factor kappa B activation through CD14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory kappa B alpha degradation?. Alcohol. Clin. Exp. Res. 26 11 (2002) 1609-1614
46. Mathurin P., Deng Q., Keshavarzian A., Choudhary S., Holmes E., and Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32 (2000) 1008-1017
47. McKenizie S.J., Baker M.S., Buffington G.D., and Doe W.F. Evidence for oxidant-induced injury to epithelial cells during inflammatory bowel disease. J. Clin. Invest. 98 1 (1996) 136-141
48. Menconi M.J., Salzman A.L., Unno N., Ezzell R.B., Casey D.M., Brown D.A., Tsuji Y., and Fink M.P. Acidosis induces hyperpermeability in Caco-2BBe cultured intestinal epithelial monolayers. Am. J. Physiol. 272 (1997) G1007-G1021
49. Menon S.D., Qin S., Guy R.G., and Tan Y.H. Differential induction of nuclear NF-kB protein phosphatase inhibitors in primary and transformed human cells. J. Biol. Chem. 268 35 (1993) 26805-26812
50. Meunier V.M., Bourrie Y., Berger Y., and Fabre G. The human intestinal epithelial cell line Caco-2: pharmacological and pharmacokinetics applications. Cell Biol. Toxicol. 11 (1995) 187-194
51. Moon R.M., Parikh A.A., Pritts T.A., Fischer J.E., Cottongim S., Szabo C., Salzman A.L., and Hasselgren P.O. Complement component C3 production in IL-1 beta-stimulated human intestinal epithelial cells is blocked by NF-kappa B inhibitors and by transfection with Ser 32/36 mutant I kappa B alpha. J. Surg. Res. 82 (1999) 48-55
52. Nanji A., Khettry U., and Hossein-Sadrzadeh S.M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med. 205 (1994) 243-247
53. Neurath M.F., Pettersson S., Buscheneedle K.M.Z., and Strober W. Local administration of antisense phosphorothioate oglionucleotides to the p65 subunit of NF-kB abrogates established experimental colitis in mice. Nat. Med. 9 2 (1999) 998-1004
54. Renard P., Ernest I., Houbion A., Art M., Le Calvez H., Raes M., and Remacle J. Development of a sensitive multi-well colorimetric assay for active NF-KappaB. Nucleic Acids Res. 29 4, e21 (2001) 1-5
55. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P.A., Scholrerich J., and Gross V. Nuclear factor kB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115 (1998) 357-369
56. Sanders S.E., Madara J.L., Mcgurick D.K., Gelman D.S., and Colgan S.P. Assessment of inflammatory events in epithelial permeability: a rapid screening method using fluorescein dextrans. Epithelial Cell Biol. 4 (1995) 25-34
57. Schmidt K.N., Amstad P., Cerutti P., and Baeuerle P.A. Identification of hydrogen peroxide as the relevant messenger in the activation pathway of transcription factor NF-kappa B. Adv. Exp. Med. Biol. 387 (1996) 63-68
58. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
59. Schreiber S., Nikolaus S., and Hampe J. Activation of Nuclear Factor kB in inflammatory bowel disease. Gut 42 (1998) 477-484
60. Tang G., and Leppla S.H. Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect. Immun. 67 6 (1999) 3055-3060
61. Unno N., Menconi M.J., Smith M., and Fink M.P. Hyperpermeability of intestinal epithelial monolayers induced by NO: effect of low extracellular pH. Am. J. Physiol. 272 (1997) G923-G934
62. Yamada T., Spartor R.B., Marshall S., Special R.D., and Grisham M.B. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterol. 104 (1993) 759-771
63. Yin M.J., Yamamoto Y., and Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkB kinase. Nature 396 (1998) 77-80